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Murine interleukin-10 (IL-10) is produced by type 2 helper (Th2) cells and selectively inhibits cytokine
synthesis by type 1 helper (Thl) cells, whereas human IL-10 is produced by and inhibits proliferation and
cytokine synthesis by both Thl and Th2 subsets. This study reports that bovine IL-10 mRNA is expressed by
ThO, Thl, and Th2 clones of bovine T cells specific for either Babesia bovis or Fasciola hepatica but not by two
CD8+ T-cell clones. The antigen-induced proliferative responses of all three subsets of CD4+ cells were
inhibited by human IL-10, and low levels (10 U/ml) of exogenous human IL-2 restored the suppressed response.
However, proliferation of one Thl clone was never inhibited but was enhanced by IL-10. Human IL-10 also
inhibited the expression of gamma interferon and IL-4 mRNA in ThO clones. In the absence of accessory cells
(AC), the responses of Th clones to concanavalin A or IL-2 were not inhibited by IL-10, whereas antigen-
specific responses of Thl and Th2 cells were reduced when IL-l0-pretreated macrophages were used as AC.
Together, our results with bovine T cells support the concept that IL-10 primarily affects AC function and does
not directly inhibit CD4+ T cells and demonstrate that the immunoregulatory effects of IL-10 are not selectively
directed at Thl populations, as they are in mice.
Interleukin-10 (IL-10) is a multifunctional cytokine, first
described as cytokine synthesis inhibitory factor (17), that is
produced primarily by CD4+ T cells, monocytes/macrophages
(M4), and B cells (reviewed in references 21, 26, 30, and 36).
In addition, IL-10 has a number of immunostimulatory prop-
erties in vitro, including the enhancement of growth and
differentiation of B cells (9, 29), thymocytes and peripheral T
cells (23), mast cells (32), and cytotoxic T cells (8). In the
original studies by Fiorentino and colleagues, IL-10 was shown
to be produced in the mouse by the type 2 helper (Th2) subset
of CD4+ T cells and to selectively inhibit cytokine production
by type 1 helper (Thl) cells (17). IL-10 also inhibited
proliferation of antigen-driven Thl clones in the presence of
irradiated spleen cells or purified M( (22). Studies with
murine Thl clones showed that synthesis of gamma inter-
feron (IFN-y) was consistently suppressed, whereas synthe-
sis of additional cytokines, including IL-2, was inhibited in
some clones but not in others (17). These results paralleled
those demonstrating inconsistent or variable inhibition by
IL-10 of antigen-driven Thl cell proliferation (17, 22). IL-10
did not inhibit cytokine expression by Th2 clones, including
IL-4 and IL-5, leading to the concept that IL-10 is an
important immunoregulatory cytokine for delayed-type hy-
persensitivity reactions.
In contrast to what was found in the mouse, studies with
human Th clones revealed that IL-10 was produced by ThO,
Thl, and Th2 cells (11, 33, 35) and inhibited cytokine produc-
tion and proliferation by all three Th subsets (11-13). In both
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species, reduced proliferation of resting T cells against mito-
gens in the presence of IL-10 correlated with reduced produc-
tion of IL-2 (15, 31). In the mouse, IL-2 partially restored the
response (15), whereas both IL-2 and IL-4 were effective at
reversing the suppressive effects of IL-10 on human T-cell
responses (31).
Additional differences in the mode of action of IL-10 in the
human and mouse systems were observed in studies demon-
strating the effects of IL-10 on antigen-presenting or accessory
cells (AC). In both species, IL-10 downregulated cytokine
synthesis by Th cells only in the presence of AC, inhibiting M+,
but not B cells as AC for presentation of antigen or superan-
tigen (12, 17, 18) or as costimulatory cells for mitogen- and
IL-2-driven responses (15). However, inhibition of human M4
function correlated with diminished major histocompatibility
complex (MHC) class II expression (12), whereas murine
MHC class II expression on M4 was not affected by IL-10 (14,
15, 18). It was subsequently found that the diminished AC
function of IL-10-treated mouse M4 was caused by suppressed
induction of the activation antigen B7 (14).
Because IL-10 is an important immunoregulatory cytokine
with distinctly different effects on T cells from mice and
humans, characterization of IL-10 in other species is important
to fully understand the biology of this cytokine and its potential
for clinical application. We recently described a cDNA encod-
ing bovine IL-10 (19). The nucleotide sequence has 84 and
79% homology with the human and mouse cDNAs, respec-
tively, and the predicted amino acid sequence is also highly
conserved, with 77 and 71% identity, respectively. Whereas
Yssel et al. reported that maximal expression of human IL-10
occurred relatively late (after 24 h) following T-cell activation
(35), we observed that maximal expression of the bovine
transcript occurred early (8 h) after stimulation of peripheral
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TABLE 1. Characteristics of bovine T-cell clones used in this study
Donor cattle Clone Phenotype Antigen T-cell subtype (cytokine Referencespecificity mRNA[s] expressed)
Normal 99.2G7 CD8+ Unknown TO (IL-2, IL-4, IFN-'y) This study
99.2H5 CD8+ Unknown TO (IL-2, IL-4, IFN-y) This study
G2.1G8 CD4+ Unknown TO (IL-2, IL-4, IFN-y) This study
B. bovis immune C97.1C8 CD4+ B. bovis Bb-1 Thl (IL-2, IFN-y) 7
G3.2F7 CD4+ B. bovis Thl (IL-2, IFN-y) 5
C15.2G10 CD4+ B. bovis ThO (IL-2, IL-4, IFN--y) 5
C15.D10 CD4+ B. bovis ThO (IL-2, IL-4, IFN--y) 5
F. hepatica immune Gl.1H5 CD4+ F. hepatica ThO (IL-4, IFN--y) 2
G1.1H12 CD4+ F. hepatica ThO (IL-2, IL-4, IFN--y) 2
G1.3E11 CD4+ F. hepatica ThO (IL-2, IL-4, IFN-,y) 2
G1.3G10 CD4+ F. hepatica Th2 (IL-4) 2
G1.3B11 CD4+ F. hepatica Th2 (IL-4) 2
G1.2H4 CD4+ F. hepatica Th2 (IL-4) 2
G1.3G4 CD4+ F. hepatica Th2 (IL-4) 2
The T-cell subtype is designated as unrestricted (TO or ThO), Thl, or Th2. The subtype was determined by the profile of cytokines expressed following activation
by either ConA or antigen, as indicated in parentheses.
blood mononuclear cells (PBMC), remained elevated until 24
h, and then declined (19).
The present study was designed to further characterize IL-10
expression by and regulation of different bovine T-cell subsets
and employed clones of bovine Th cells specific for either the
hemoprotozoan parasite Babesia bovis (5, 7) or the trematode
parasite Fasciola hepatica (2). The CD4+ clones were recently
characterized as either ThO, Thl, or Th2 cells by the expression
patterns of IL-2, IL-4, and IFN--y mRNA. Unlike murine Th
clones, the majority of more than 25 bovine Th clones ex-
pressed unrestricted cytokine profiles, reminiscent of what has
been reported for some antigen-specific human Th clones (24,
25, 27). Selected bovine T-cell clones, including CD8+ T cells
and CD4+ T-cell clones representing different Th subsets,
were characterized for the expression of IL-10 mRNA and the
regulation of proliferation and cytokine expression by human
IL-10. We report that, like human T cells, IL-10 was expressed
by ThO, Thl, and Th2 subsets of bovine Th cells irrespective of
their cytokine repertoires. Furthermore, antigen-specific pro-
liferation of Th clones belonging to all three subsets was
strongly suppressed by exogenous IL-10. Importantly, only one
of two Thl clones could be inhibited by IL-10, indicating a
differential effect by IL-10 on Thl cell proliferation. These
findings support the view that the cytokine network that
regulates Thl and Th2 cells described for inbred stains of mice
may not be generally applicable to all mammals (11). Although
bovine T-cell responses are in many ways more like those
described for human than for murine T cells, characteristics
unique to the bovine cellular immune response are also
apparent from these studies.
MATERIALS AND METHODS
Bovine T-cell clones. Three concanavalin A (ConA; Sigma
Chemical Co., St. Louis, Mo.)-induced T-cell clones were
obtained from normal donor cattle C99 and G2. PBMC were
stimulated for 3 to 4 days with ConA (5 ,ug/ml) in complete
RPMI 1640 medium (4), and lymphoblasts were cloned by
distributing a statistical average of 0.3 or 1 cell per well of
96-well round-bottomed plates as described before (3). The
cloning frequencies ranged from 19 to 25%, and clones were
maintained in medium containing 10% bovine T-cell growth
factor (TCGF) (3) in the absence of irradiated PBMC as a
source of AC. Two of the clones (99.2G7 and 99.2H5) ex-
pressed the cell surface phenotype CD4- CD8+, and one clone
(G2.1G8) expressed the Th cell phenotype CD4+ CD8-. The
antigen specificity of these three clones is not known.
Antigen-specific CD4+ Th cell clones were obtained from
PBMC of cattle immune to either B. bovis or F. hepatica. The
cloning procedures and characterization of the Th clones were
described in detail in previous publications (2, 5, 7). The clones
were cryopreserved and, upon thawing, were stimulated on a
weekly basis with irradiated autologous PBMC as a source of
AC, 10% bovine TCGF, and antigen. The majority of B.
bovis-specific Th clones were stimulated with a crude mem-
brane preparation of B. bovis merozoites (4), whereas one
clone (C97.1C8) was stimulated with a recombinant form of
the 77-kDa apical complex-associated protein expressed as a
fusion protein with glutathione-S-transferase, designated Bb-
1-GST (7). All F. hepatica-specific clones were stimulated with
adult worm extract (2). The Th subtypes of the antigen-specific
Th clones were characterized previously as ThO, Thl, or Th2
cells by the differential expression of IL-2, IL-4, and IFN-y
mRNA. Table 1 summarizes the characteristics of the T-cell
clones used in this study.
Stimulation of T cells for analysis of cytokine mRNA.
Antigen-specific T-cell clones were collected 6 or 7 days after
the last stimulation with antigen and AC and washed and
cultured for 8 or 24 h at a concentration of 1.3 x 106 cells per
ml of complete medium containing ConA (2.5 ,ug/ml) in the
absence of AC. Non-antigen-dependent TCGF-maintained
clones were collected 3 or 4 days after TCGF stimulation and
stimulated with ConA for 8 or 18 h. To determine the effects of
human IL-10 on the induction of cytokine mRNA expression
by the Th clones, selected clones were cultured at a concen-
tration of 1.3 x 106 cells per ml for 13 h with 2 x 106 AC and
25 ,ug of F. hepatica antigen per ml in the absence or presence
of 20 ng of human recombinant IL-10 (Genzyme Corp.,
Cambridge, Mass.) per ml (equivalent to 10 U/ml). As a
positive control for cytokine mRNA expression, PBMC were
stimulated at a density of 2 x 106 cells per ml with ConA for
15 or 18 h. Negative control cultures consisted of AC plus
antigen or murine WEHI-164 fibroblasts. Total cellular RNA
was prepared from the cells by using 2 ml of RNAzol B
(Biotecx Laboratories, Inc., Houston, Tex.) per 107 cells, as
specified by the manufacturer.
Northern (RNA) blot analysis. Northern blotting was per-
formed to identify the expression of IL-2, IL-4, IFN-y, and
IL-10 mRNAs as detailed previously (2, 5, 7, 19). Briefly, equal
amounts of RNA (20 ,ug per lane unless otherwise indicated)
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were size-fractionated in formaldehyde-morpholinepropane-
sulfonic acid (MOPS)-1.6% agarose gels. Ethidium bromide-
stained gels were visualized to confirm the integrity of the
RNA and to verify that equal amounts of total RNA were
loaded in each lane. RNA transferred to GeneScreen nylon
membranes (Dupont NEN, Boston, Mass.) was then hybrid-
ized to 32P-labeled cDNA probes for IL-2 (28), provided by
Ray Reeves, Washington State University; IL-4 (20), provided
by Dirk Dobbelaere, University of Bern, Bern, Switzerland;
IFN--y, provided by Arjun Singh, Genentech, San Francisco,
Calif.; IL-10 (19); and actin (10), provided by Angelika Ehr-
feld, Max Planck Institute for Immunology, Freiburg, Ger-
many. The cDNAs were labeled with 32P by the random
priming method with a kit from Boehringher Mannheim,
yielding probes with a specific activity of 1 x 109 to 2 x 109
cpm/,Lg. The membranes were then exposed to Hyperfilm
(Amersham Corporation, Arlington Heights, Ill.) at -80°C.
The approximate sizes of the transcripts (in kilobases) were
determined from nucleic acid molecular size standards (0.24-
to 9.5-kb RNA ladder; GIBCO BRL, Gaithersburg, Md.) that
were electrophoresed, transferred to nylon and stained with
methylene blue.
To quantify the effect of IL-10 on cytokine mRNA expres-
sion, Northern blots of RNA prepared from Th clones cultured
with antigen and AC with or without IL-10 were scanned with
a Betascope model 603 Blot Analyzer (Betagen Corp.,
Waltham, Mass.), and the 32p signals were counted for 30 min
and recorded as cpm. The cpm obtained for the cytokine
signals were compared with those obtained by hybridization
with the bovine actin probe and corrected according to the
relative intensity of the actin hybridization.
RT-PCR. cDNA was produced from 0.5 jig of total RNA,
isolated as described above from antigen-stimulated Th clones
cultured with or without IL-10, with a GeneAmp RNA PCR kit
(Perkin-Elmer Cetus, Norwalk, Conn.) and following the man-
ufacturer's protocol, with the addition of 2 ,uCi of [32P]ATP
per sample. The bovine IL-2-specific (28) and IL-4-specific
(20) primers were provided by Dirk Dobbelaere, and actin-
specific primers were selected from the published sequence
(10) by using the MacVector DNA analysis software (IBI, New
Haven, Conn.). First-strand cDNA synthesis was performed
with a GTC thermal cycler (Precision Scientific, Chicago, Ill.),
employing reverse transcriptase and bovine actin (5'-ACG
TAGCAGAGCITTCTCCTlGATG-3'), IL-2 (5'-GAGAGGC
ACT1lAGTGATC-3'), or IL-4 (5'-GTClrFCAGCGTACTT
GT-3') antisense primers (20 to 34 pmol), with an initial
15-min incubation at 48°C followed by a 5-min incubation at
99°C. Actin (5'-CCTTTTACAACGAGCTGCGTGTG-3'),
IL-2 (5'-ACATTTGACTTTTACGCGCCCAAGGT-3'), or
IL-4 (5'-TGCATTGTTAGCGTCTCCT-3') sense primers (20
to 32 pmol) were then added to the reaction mixtures, and the
mixtures were incubated at 95°C for 4 min. Taq polymerase
was added, and the mixtures were further amplified for 35
cycles (94°C, 1 min; 50°C, 1 min; 72°C, 2 min). Fourteen
microliters of each PCR product was then electrophoresed on
a 1% agarose gel and stained with ethidium bromide. The gels
were photographed and exposed to autoradiograph film for
4 h to visualize the [32P]ATP incorporation. Cytokine-specific
bands were then cut from the gels and quantified through
Cerenkov radiation. The specificity of the primers and identity
of the product bands were previously verified by Southern
blotting with reverse transcription (RT)-PCR products ob-
tained from ConA-stimulated PBMC and radiolabeled IL-2,
IL-4, and actin cDNA probes.
IFN--y assay. IFN-y activity in the supernatants of Th clones
cultured with antigen and AC with or without IL-10 was
measured in serially diluted samples with a bovine IFN--y-
specific enzyme-linked immunosorbent assay (ELISA) kit
(IDEXX Corp., Westbrook, Maine) according to the manu-
facturer's instructions. The IFN-y activity in the culture super-
natants was determined by comparison with a standard curve
obtained with a supernatant from a B. bovis-specific Th clone
that contained 400 U of IFN-y per ml (previously determined
by the neutralization of vesicular stomatitis virus [6]).
Preparation and IL-10 treatment of bovine M4+. PBMC
were cultured in 100-mm petri dishes at a density of5 x 106
cells per ml for 1 to 2 h. The nonadherent cells were removed
by gentle washing. The medium was replaced, and the adher-
ent cells were then cultured for 20 h with medium in the
presence or absence of 20 ng of IL-10 per ml (1-day M+~).
Alternatively, plastic-adherent cells were cultured for 6 days in
complete RPMI medium and then treated overnight with
IL-10 (7-day M+). The medium and any nonadherent cells
were removed, and adherent cells were removed following
treatment with warm (37°C) Ca2+- and Mg2+-free Hanks'
balanced salt solution (GIBCO, Grand Island, N.Y.) contain-
ing 0.1% disodium EDTA. The surface phenotypes of the MX
populations were characterized by flow cytometry after stain-
ing the cells with a bovine monocyte-specific monoclonal
antibody (MAb), IL-A24 (16), and a bovine MHC class
II-specific MAb, IL-A21. Both antibodies were obtained from
John Ellis, University of Saskatchewan, Saskatoon, Canada.
Macrophages were washed twice before use in proliferation
assays.
Lymphocyte proliferation assays and neutralization of IL-
10. Proliferation assays were carried out in duplicate wells of
half-area 96-well plates (Costar, Cambridge, Mass.) at 37°C, in
a humidified atmosphere of 5% CO2 in air for 3 days, as
described before (2, 5, 7). Each well (100 ,ul total volume)
contained complete medium, responder T cells added at a final
concentration of 3 x 105 cells per ml, and the stimulating agent
in the absence or presence of 2 x 106 autologous AC per ml.
ConA was used at a final concentration of 2.5 j,g/ml, recom-
binant human IL-2 (Boehringher Mannheim Biochemicals,
Indianapolis, Ind.) was used at 10 U/ml, and specific antigen
was used at 5 to 50 jig/ml of complete medium. IL-10 was
included in some assay wells at a final concentration of 0.3 to
80 ng/ml. Results are presented as the mean cpm ± 1 standard
deviation (SD) for duplicate cultures.
To neutralize IL-10 activity, goat anti-human IL-10 immu-
noglobulin G (IgG), with a reported dosage to neutralize 50%
of biological activity (ND50) of 5 to 10 ,ig/ml (R&D Systems,
Minneapolis, Minn.), or control goat IgG (provided by D. Scott
Linthicum, Texas A & M University) was incubated in the
assay plates with an equal volume of IL-10 for 30 min at 37°C
before the addition of T cells and AC, to yield final concen-
trations of 1.25 to 20 ,ug of IgG and 10 ng of IL-10 per ml.
Statistical analysis. The one-tailed Student t test was used to
determine the levels of significance between control and
experimental cultures.
RESULTS
IL-10 mRNA is expressed by ThO, Thl, and Th2 T-cell
clones. Studies with murine Th-cell clones have shown that
Th2 cells but not Thl cells produce IL-10 (17), whereas both
Thl- and Th2-like subsets of human Th-cell clones were shown
to express this cytokine (11, 35). We therefore proposed to
analyze the expression of IL-10 by different subsets of bovine T
cells. Table 1 describes the characteristics of a panel of 14
T-cell clones examined in this study. Clones with unknown
specificity, including two CD8+ and one CD4+ clone, were
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FIG. 1; Northern blot analysis of IL-10 mRNA expression by
bovine Thl, ThO, and Th2 clones. RNA was prepared from B.
bovis-specific Thl and ThO clones and F. hepatica-specific Th2 clones
that were stimulated for 8 h with ConA. RNA was prepared from a
CD8+ clone, 99.2H5, stimulated for 8 h with ConA as a negative
control and from PBMC stimulated for 18 h (ConA Bl) as a positive
control for IL-10 mRNA expression. Total RNA (20 ,ug) was electro-
phoresed on agarose gels, transferred to nylon membranes, and
hybridized successively with bovine IL-10 and actin probes or with
IL-2, IL-4, or IFN-y probes. The IL-10-hybridized membranes were
exposed for 3 days (clone 99.2H5, ConA Bl, and clone C97.1C8) or 4
days (all other clones), and the actin-hybridized filters were exposed
for 2 h. The results of hybridization with the other cytokine probes
were obtained in separate experiments (2, 5, 7), and the membranes
were exposed for the following time periods: IFN-y, 2 to 5 h; IL-2 and
IL-4, 2 days (99.2H5), 7 and 10 days (C97.1C8), 7 days (ConA Bl,
C15.lD10, and C15.2G10), and 4 days (G1.3G4, G1.3G10, G1.3B11,
and G1.2H4). The approximate sizes (in kilobases) of the indicated
cytokine probes are shown on the left.
derived from ConA-stimulated cultures of T cells from normal
cattle. The remaining antigen-specific Th-cell clones were
obtained from cattle immune to either B. bovis or F. hepatica.
Previous studies have characterized the antigen-specific clones
as belonging to either ThO, Thl, or Th2 subsets based on their
expression of mRNA for IL-2, IL-4, and IFN--y. ThO clones
expressed either all three cytokines or IL-4 and IFN--y, whereas
Thl clones expressed IL-2 and IFN-y and no IL-4, and Th2
clones expressed IL-4 and little or no IFN-,y or IL-2 (Fig. 1 and
2A) (2, 5, 7). When the panel of T-cell clones was examined for
IL-10 mRNA expression following stimulation with ConA,
CD4+ T-cell clones belonging to all of the Th-cell subsets
expressed this cytokine, whereas neither CD8+ clone ex-
pressed IL-10 (Fig. 1 and 2B). There were no consistent
differences in the levels of IL-10 mRNA expression among the
different Th-cell subsets; if anything, Thl clones appeared to
express more cytokine message than Th2 clones (Fig. 1).
Comparison of mRNA obtained at 8 or 18 to 24 h following
ConA stimulation revealed maximal expression of IL-10
mRNA at the earlier time point in F. hepatica-specific ThO
clones Gl.lH5 and G1.1H12 (Fig. 2A) as well as in the
ConA-induced ThO clone G2.1G8 (Fig. 2B). In fact, the IL-10
transcripts were barely detectable by 18 to 24 h, in contrast to
IFN--y transcripts, which were still present at the later time
points. CD8+ clone 99.2G7 did not express IL-10 mRNA at
either time point examined (Fig. 2B). Two CD4- CD8- CD3+
ylb T-cell-receptor-positive (TcR+) clones obtained from F.
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FIG. 2. Northern blot analysis of IL-10 mRNA expression in
bovine T-cell clones stimulated for different time periods. F. hepatica-
specific ThO clones G1.1H5 and G1.lH12 (A) and ConA-induced
CD4+ clone G2.1G8 and CD8+ clone 99.2G7 (B) were stimulated with
ConA for 8, 18, or 24 h. RNA was prepared from PBMC stimulated
with ConA for 18 h as a positive control. Total RNA (20 ,ug) was
electrophoresed on agarose gels, transferred to nylon membranes, and
probed with the indicated cytokine probes, including actin as a control
for quantification of RNA. The filters were exposed for the following
times: (A) IL-2, 3 days; IL-4, 1 day; IFN--y, 4 h; IL-10, 7 days; actin, 1
h; (B) IL-2 and IL-4, 4 days; IFN-y, 3 h; IL-10, 7 days; actin, 3 h. The
approximate sizes (in kilobases) of the indicated cytokine probes are
shown on the left.
hepatica-stimulated T-cell lines and freshly prepared antigen-
presenting cells did not express IL-10 mRNA (data not pre-
sented), ruling out potential contamination of the T-cell
mRNA with mRNA from residual antigen-presenting cells.
These results show that IL-10 expression by bovine T-cell
subsets is similar to that described for human Th-cell clones
(11, 35) and is not restricted to the Th2 subset, as described for
mice (17). However, the kinetics of expression of bovine IL-10
mRNA in the Th clones differ from those for human T-cell
clones, in which it was reported that maximal IL-10 mRNA
expression occurred 24 h following activation (35).
Human IL-10 inhibits antigen-induced proliferation of ThO,
Thl, and Th2 clones. The finding that IL-10 mRNA is ex-
pressed by ThO and Thl as well as Th2 cells derived from
parasite-infected cattle prompted us to determine if all Th-cell
subsets can be downregulated by exogenous IL-10, as recently
reported for human Thl and Th2 clones (11, 12). Table 2
presents the baseline levels of antigen-induced proliferation by
representative T-cell clones used for the IL-10 inhibition
studies presented in Fig. 3. All of the antigen-specific Th-cell
clones proliferated to antigen in the absence of IL-2, although
IL-2 potentiated the response of all clones. When human IL-10
was added to the T cells and AC at the initiation of the
proliferation assay, a dose-dependent inhibition of prolifera-
tion of five of six CD4+ clones in response to antigen was
observed (Fig. 3). Maximal levels of inhibition usually occurred
with 20 ng of IL-10 per ml, although in some experiments 80 ng
of IL-10 per ml was more effective. IL-10 was not selectively
inhibitory for a given Th-cell subset but inhibited antigen-
driven proliferation of ThO, Thl, and Th2 clones. As illustrated
in Fig. 3, 20 ng of IL-10 per ml inhibited proliferation of Th2
INFECT. IMMUN.
 o
n
 Septem
ber 21, 2018 by guest
http://iai.asm
.org/
D
ow
nloaded from
 
IL-10 IS EXPRESSED BY AND REGULATES BOVINE Th SUBSETS 4701
TABLE 2. Proliferative responses of Th-cell clones against
antigen or antigen and IL-2
Radioactivity (mean cpm ± SD) incorporated
T-cell clone by Th clones stimulated witha:
(Th subtype)
Medium Antigen Antigen + IL-2
C97.1C8 (Thl) 24 ± 5 12,907 ± 288 156,778 + 3,303
G3.2F7 (Thl) 169 ± 48 18,448 ± 2,152 71,061 ± 542
G1.1H5 (ThO) 158 ± 22 18,977 ± 126 36,648 ± 3,315
G1.lH12 (ThO) 635 ± 24 6,001 ± 1,700 15,074 ± 1,191
G1.3B11 (Th2) 175 ± 6 3,566 ± 137 12,339 + 852
G1.3G10 (Th2) 663 ± 75 13,856 ± 648 24,820 + 662
a Th-cell clones (3 x 104 cells) were cultured for 3 days with 2 x 105 irradiated
PBMC as AC and antigen, which consisted of Bb-1-GST (25 ,g/ml) for clone
C97.1C8, the crude membrane fraction of B. bovis (Texas isolate) merozoites (25
,ug/ml) for clone G3.2F7, or F. hepatica adult worm extract (50 ,g/ml) for clones
G1.1H5, G1.1H12, G1.3G10, and G1.3B11, in the absence or presence of 10 U
of IL-2 per ml. Incorporation of radioactivity is expressed as the mean cpm of
[1"I]deoxyuridine in duplicate samples ± 1 SD. Proliferative responses of the
T-cell clones cultured with antigen or antigen plus IL-2 were shown to be
significantly different from proliferative responses of T-cell clones cultured with
medium alone (P < 0.05) by the Student one-tailed t test.
clones G1.3G10 and G1.3B11 against 50 p,g of F. hepatica adult
worm antigen per ml by 76 and 87%, respectively. The
responses of ThO clones G1.1H5, G1.lH12, and G1.3E11 (not
shown) were similarly inhibited by 59, 61, and 38%, respec-
tively, and antigen-specific proliferation of Thl clone C97.1C8
was inhibited by 61% in the presence of 80 ng of IL-10 per ml.
More effective inhibition of T-cell proliferation was generally
obtained when a suboptimal antigen concentration was used.
For example, the response of Th2 clone G1.3G10 against 10 ,ug
of F. hepatica antigen per ml (6,356 ± 114 cpm) was completely
inhibited by 20 ng of IL-10 per ml (375 ± 26 cpm). Interest-
ingly, in three experiments, Thl cell clone G3.2F7 could not be
inhibited by any concentration of IL-10 in the presence of
either a low (5 ,ug/ml) or high (25 pLg/ml) concentration of B.
bovis antigen. In fact, in two of three experiments, IL-10
enhanced the proliferative response of this clone to antigen
(Fig. 3). It thus appears that human IL-10 can both inhibit and
costimulate bovine T cells, as reported previously for murine
IL-10 in studies demonstrating costimulatory activity for thy-
mocytes and peripheral T cells (23).
Inhibition of human T-cell proliferation by IL-10 is associ-
ated with a reduction in endogenous IL-2 and IL-4 production
(11, 13, 31), and suppressed proliferation could be restored by
the addition of IL-2 (13, 31) or IL-4 (31) to the cultures.
Human IL-2 similarly reversed the suppressed proliferative
responses of the five bovine Th-cell clones cultured with IL-10.
As shown in Fig. 3, nearly complete (96%) restoration of the
response was achieved with Thl clone C97.1C8 and ThO clone
G1.1H12, both of which expressed IL-2 mRNA upon ConA
stimulation (Fig. 1 and 2A) (5, 7), whereas only partial
restoration (69 to 79%) of the response was achieved with Th2
clones G1.3G10 and G1.3B11 and ThO clone G1.1H5 that did
not express IL-2 mRNA (Fig. 1 and 2A) (2). These results
are consistent with the hypothesis that IL-10 acts, either
directly or indirectly, to inhibit bovine T-cell proliferation
against antigen by inhibiting the synthesis of autocrine T-cell
growth factors.
Inhibitory effect of IL-10 is neutralized by goat anti-human
IL-10 antibody. Purified IgG fractions of goat anti-human
IL-10 neutralizing antibody and control goat IgG were em-
ployed in blocking studies to verify the inhibitory activity of
human recombinant IL-10 for bovine Th cells. When anti-
IL-10 IgG or control goat IgG ranging from 1 to 20 ,ug/ml was
incubated with IL-10 (10 ng/ml) for 1 h before the addition of
Th cells, antigen, and AC to the assay mix, the inhibitory effect
of IL-10 was completely reversed by anti-IL-10 antibody in a
dose-dependent manner (Fig. 4). For four of five clones tested,
the ND50 of the anti-IL-10 IgG neutralizing 10 ng of IL-10 per
ml ranged from approximately 6 to 7.5 ,ug/ml and was approx-
imately 15 ptg/ml for the fifth clone, G1.1H12. For some clones,
the levels of antigen-induced proliferation were enhanced in
the presence of 20 ,ug of anti-IL-10 IgG per ml whether
exogenous IL-10 was present in the assay (as shown for clones
G1.3G10 and G1.1H5 in Fig. 4) or absent (Table 3). As
presented in Table 3, the antigen-specific responses of four
clones were augmented in the presence of anti-IL-10 antibody
but not control goat IgG. The fifth clone, G3.2F7, which was
not suppressible by IL-10, did not express enhanced prolifer-
ation in the presence of specific antibody. Together, these
results demonstrate that the inhibitory activity of human IL-10
for bovine T cells is specifically mediated by the cytokine and
suggest that anti-IL-10 antibody may neutralize endogenous
bovine IL-10 produced by the T cells and/or AC, as indicated
by others using a mouse model (15).
IL-10 inhibits the expression of cytokine mRNA by antigen-
stimulated ThO clones. Since IL-10 was originally described as
cytokine synthesis inhibitory factor (17), we wished to deter-
mine whether human IL-10 was able to affect cytokine synthe-
sis by antigen-stimulated bovine T cells. Preliminary studies
with two ThO clones revealed a suppressive effect of IL-10 on
transcription of both IFN--y and IL-4 mRNAs. Analysis of
IFN--y mRNA in ThO clones by Northern blotting (Fig. SA)
and quantification of the cytokine mRNA signals analyzed with
the Betascope Blot Analyzer revealed 72 and 45% reduction in
the IFN-y signals of clones G1.3E11 and G1.1H12, respec-
tively, when normalized to the actin signal. IFN--y levels in the
supernatants of clone Gl.1H12 were low (<10 U/ml), so it was
not possible to detect significant differences in IFN--y levels in
supernatants of IL-10-treated or untreated cells. However,
IL-10 inhibited the level of IFN--y produced by clone G1.3E11
by 38%, which fell from 61 to 38 U/ml. Because the signals for
IL-2 and IL-4 mRNA were too weak to quantify on the
Northern blots (data not shown), RT-PCR was performed with
IL-2-, IL-4-, or actin-specific primers to evaluate the effects of
IL-10 on IL-2 and IL-4 mRNA expression by these ThO clones
(Fig. 5B). As controls, RNA prepared from murine WEHI-164
fibroblasts (negative control for IL-2 and IL-4) or bovine
PBMC activated for 15 h with ConA (positive control) was
used for identical RT-PCRs. Compared with the control
ConA-stimulated PBMC PCR product, which yielded a single
band of the expected 306-bp size, several bands of inappropri-
ate size were observed on the ethidium bromide-stained gels
of amplified PCR products from the ThO clones. Similar
patterns of nonspecific reactivity were observed with the mu-
rine cell line, indicating a nonspecific reaction due to insuffi-
cient mRNA in the starting material of the ThO clones.
However, the IL-4 PCR products obtained from the ThO
clones yielded the expected 421-bp fragment observed with the
positive control, with visibly less product from the IL-10-
treated cells. The radiolabeled IL-4 PCR products were ex-
cised from the gels and quantified in a scintillation counter.
When the cpm present in the IL-4 PCR products for the two
clones were normalized to the cpm present in the actin PCR
products, there was 80 and 75% less IL-4 product from
IL-10-treated clones G1.3E11 and G1.1H12, respectively, com-
pared with PCR products from untreated cells. Because of the
low levels of expression of these cytokines following stimula-
tion with antigen and AC (5), we were unable to detect IL-2 or
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FIG. 4. Effects of anti-human IL-10 antibody on IL-l0-mediated suppression of antigen-specific proliferative responses of bovine Th-cell clones.
Selected Th clones were stimulated in a 3-day proliferation assay with antigen and AC in the absence (open squares) or presence of 10 ng of human
IL-10 per ml and 0 to 20 jig of either goat anti-human IL-l0 IgG (open circles) or control goat IgG (solid circles) per ml. Results are presented
as the mean cpm of duplicate cultures ± 1 SD.
IL-4 activity in the supernatants of antigen-stimulated ThO
clones (data not shown).
IL-10 directly inhibits a CD8+ T-cell clone but not antigen-
specific CD4+ Th clones stimulated with ConA or IL-2. To
determine whether T-cell proliferation could be inhibited
directly by IL-10, as recently reported for human Th-cell clones
(13), T-cell clones were stimulated with ConA in the presence
or absence of AC and IL-10 (Table 4). A dose-dependent
inhibition of the proliferative response to ConA by CD8+
clone 99.2G10 was obtained with IL-10, and the degree of
inhibition (51%) by 20 ng of IL-10 per ml was nearly identical
whether AC were absent or present. This result provides
evidence that this CD8+ T-cell clone can be directly inhibited
by IL-10. In contrast, a direct effect of IL-10 on CD4+ T-cell
proliferation induced by ConA was not observed. Thl clone
C97.1C8 and ThO clone G1l.H12 responded to ConA in the
absence of AC, but the response was not inhibited by IL-10 in
either the absence or presence of AC. In contrast, Th cell
TABLE 3. Effect of anti-human IL-10 antibody on
Th-cell proliferation against specific antigen
Radioactivity (mean cpm + SD) incorporated
T-cell clone by Th clones cultured witha: Response
(Th subtype) Medium Antigen + antigen + control)
control IgG anti-IL-10 IgG
C97.1C8 (Thl) 65 ± 10 571 + 16 1,317 ± 335 231
G3.2F7 (Thl) 602 ± 38 7,313 ± 782 7,360 ± 871 101
Gl.1H5 (ThO) 26 ± 5 5,073 ± 13 9,426 ± 561 186**
G1.1H12 (ThO) 30 ± 9 6,888 ± 300 10,246 ± 624 149*
G1.3G10 (Th2) 98 ± 21 10,577 ± 109 13,039 + 1,249 123
a Th-cell clones were stimulated with specific antigen as described in Table 2,
footnote a. Control goat IgG or goat anti-IL-10 IgG was added to identical
cultures at a final concentration of 20 ,ug of protein per ml. Incorporation of
radioactivity is expressed as the mean cpm of ['2I]deoxyuridine in duplicate
samples ± 1 SD.
b Data are expressed as the percentage of the response of the Th clone against
antigen with control IgG. The level of significance determined by the one-tailed
Student t test is indicated: *, P < 0.05; **, P < 0.01.
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FIG. 5. Effects of IL-10 on the expression of IFN--y and IL-4
mRNA in bovine ThO clones. T-cell clones G1.H12 and G1.3E11 were
activated for 13 h with antigen and AC in the absence (-) or presence
(+) of IL-10. IFN-y mRNA expression was determined by Northern
blotting (A), and IL-4 mRNA expression was determined by semi-
quantitative RT-PCR (B). (A) Total cellular RNA (10 ,ug for clone
G1.1H12 and 15 jig for clone G1.3E11) was electrophoresed on the
gels, transferred to nylon membranes, and probed successively with
IFN--y and actin cDNA probes. Membranes were exposed for the
following time periods: clone G1.lH12: IFN-,y, 48 h; actin, 9 h; clone
G1.3E11: IFN-y, 5 h; actin, 9 h. RNA was quantified by Betascope
scanning of the membranes, and the values obtained for IFN-y were
corrected according to the relative intensities of actin hybridization.
(B) RT-PCR was performed with 0.5 ,ug of RNA prepared from
IL-10-treated (+) or untreated (-) cells of clones G1.3E11 and
G1.1H12 and untreated control cells, employing IL-2-, IL-4-, or
actin-specific primers and trace amounts of 32P-labeled ATP. Control
RNA was obtained from unstimulated murine WEHI-164 cells (neg-
ative control) or ConA-stimulated bovine PBMC (positive control).
The cytokine or actin PCR products, indicated on the left, were
visualized on ethidium bromide-stained gels. To semiquantify the
mRNA, radiolabeled IL-4 and actin PCR products were excised from
the gels and counted in a scintillation counter, and the cpm in the IL-4
PCR products of the two clones were corrected according to the cpm
in the respective actin PCR products.
clones that required costimulatory AC to proliferate to ConA
(clones G1.1H5, G1.3B11, and G1.3G10) were inhibited by
IL-10 in the presence of AC. ConA did not induce IL-2 mRNA
expression in these clones (Fig. 1 and 2A) (2).
Additional evidence for the lack of a direct inhibitory effect
of IL-10 on the Th clones was shown by the inability of IL-10
to inhibit IL-2-induced proliferation of ThO, Thl, and Th2
clones in the absence ofAC (Table 5). As before, clone G3.2F7
was not inhibited by IL-10. However, when AC were present,
20 ng of IL-10 per ml did reduce IL-2-induced proliferation of
the remaining clones by 28 to 62%. The apparently greater
inhibitory effect of IL-10 on Th cell proliferation against IL-2
in the absence of antigen compared with the effect on Th cells
cultured with antigen and IL-2 (i.e., 4 to 31% inhibition; Fig. 3)
could be explained by the more potent stimulation achieved
by the combination of antigen and IL-2 that would be less
easily suppressed. In support of this hypothesis, greater sup-
pressive effects of IL-10 were achieved with suboptimal antigen
concentrations. In the absence of AC, IL-10 enhanced the
IL-2-induced proliferation of five of the six clones, again re-
flecting the differential effects of IL-10 on bovine T-cell pro-
liferation.
The reason for the lower proliferative response of clones
Gl.1H12 and G1.3B11 to IL-2 when AC were included in the
assay, as shown in Table 5, is not known. One possibility is that
inhibitory molecules, such as prostaglandin E2 released by M4
in the AC population, could inhibit bovine T-cell proliferation
(4).
TABLE 4. Effect of IL-10 on ConA-induced proliferation of
T-cell clones with and without AC
Radioactivity (mean cpm ± SD)
T-cell clone IL-2 incorporated by Th clones %
(Th subtype) mRNAa AC cultured with": Inhibi-tionc
ConA ConA + IL-10
CD8+ clone + - 13,873 1,871 6,760 ± 385 51*
99.2G7 (TO)
+ 38,050 543 18,714 + 233 51**
CD4' clones
C97.1C8 (Thl) + - 13,987 ± 3,208 25,329 ± 1,806 0
+ 55,586 22,151 69,478 ± 1,318 0
G3.2F7 (Th1) + - 46 1 84 ± 4 NR
+ 8,171 ± 305 7,428 ± 576 10
G1.lH12 (ThO) + - 2,258 ± 33 2,667 ± 101 0
+ 2,834 + 25 2,636 ± 26 7*
G1.1H5 (ThO) - - 192 + 11 327 ± 60 NR
+ 5,246 786 1,050 ± 1 80*
G1.3B11 (Th2) - - 401 ± 40 370 ± 35 NR
+ 3,507 ± 194 1,748 + 68 50**
G1.3G10 (Th2) - - 146 ± 37 36 ± 18 NR
+ 47,707 + 1,082 3,036 ± 42 94**
a Expression of IL-2 mRNA by ConA-stimulated clones.
b T cells (3 x 104) were stimulated for 3 days with ConA (2.5 ,ug/ml) or ConA
plus 2 x 105 irradiated autologous PBMC as a source of AC in the absence or
presence of human IL-10 (20 ng/ml). Results are expressed as the mean cpm ±
1 SD of duplicate cultures.
c Percent inhibition of the response against ConA plus IL-10 compared with
the baseline response against ConA without IL-10. Underlined values were
shown to be c50% and significantly lower than the response of T cells cultured
with ConA alone (*, P < 0.05; **, P < 0.01) by the Student one-tailed t test. NR,
negative response to ConA; the difference in the mean cpm between cells
cultured with ConA and cells cultured with medium was <400 cpm.
IL-10 inhibits antigen-dependent Th-cell proliferation by
indirectly inhibiting M+. Several studies have reported that
murine IL-10 can inhibit T-cell responses by indirectly inhib-
iting the AC function ofM4~(14, 15, 18), independent of MHC
class II-T-cell receptor interactions (15). Human IL-10 was
similarly shown to inhibit Mt-dependent antigen-specific T-
cell proliferation (12). However, the studies with human T cells
showed that the effect on M4 was strongly associated with
decreased MHC class II expression. In our studies, the inability
of IL-10 to inhibit ConA- or IL-2-mediated Th-cell prolifera-
tion in the absence of AC also suggested that IL-10 inhibited
antigen-dependent proliferation indirectly via the M+. To test
this hypothesis, M4X cultured from bovine peripheral blood for
1 to 2 h or 6 days were treated for 20 h with IL-10, washed, and
compared with untreated MO for the capacity to serve as AC
for the Th clones in the absence or presence of additional
IL-10 in the assay (Table 6). The purity of the Mf population
was assessed by flow cytometry. Plastic-adherent mononuclear
cells examined after 1 day of culture contained 89 to 90%
MHC class I1+ cells, and 64 to 72% of the cells expressed the
MX determinant recognized by MAb IL-A24 (data not shown),
indicating that the majority of the AC were M4+. By 6 to 7 days
of culture, the percentage of MO in the cultures increased to
95% (data not shown). M( cultured for 6 to 7 days were
usually as effective as irradiated PBMC in presenting antigen
to both Thl and Th2 clones. However, Th2 clone G1.3G10 and
ThO clone Gl.lH5 were not inhibited when stimulated with
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TABLE 5. IL-10 inhibits IL-2-induced Th-cell proliferation
only in the presence ofAC
Radioactivity (mean cpm + SD)
T-cell clone incorporated by Th clones % Inhibi-
(Th subtype) AC cultured with': tionb
IL-2 IL-2 + IL-10
C97.1C8 (Thl) - 4,594 ± 327 11,582 + 1,694 0
+ 38,038 ± 3,499 14,443 ± 1,386 62**
G3.2F7 (Thl) - 2,118 + 129 2,045 ± 14 3
+ 27,244 ± 16 28,199 ± 1,575 0
G1.1H12 (ThO) - 9,617 ± 508 12,137 ± 188 0
+ 4,205 116 2,969 +552 36
G1.1H5 (ThO) - 24,982 1,139 29,601 27 0
+ 66,723 3,897 31,582 783 53**
G1.3B11 (Th2) - 6,842 + 258 8,415 + 251 0
+ 3,554 119 2,574 275 28*
G1.3G10 (Th2) - 2,583 + 1,336 3,954 ± 195 0
+ 3,809 73 2,323 61 39**
a T cells (3 x 104) were cultured for 3 days with human IL-2 (10 U/ml) in the
presence or absence of 0.3 to 80 ng of IL-10 per ml and 2 X 105 autologous,
irradiated PBMC as AC. Experiments performed with IL-10 at 20 ng/ml are
presented. Data are presented as the mean cpm ± 1 SD of duplicate cultures.
b Percent inhibition of the response against IL-2 in the presence of IL-10
compared with the baseline response against IL-2 without IL-10. The level of
significance, determined by a one-tailed Student t test, is indicated: *, P < 0.05;
**, P < 0.01.
antigen and autologous, IL-10-treated, 7-day MX (data not
shown). In contrast, inhibition was observed with Thl clone
C97.1C8, as shown in Table 6. Treatment of autologous M4X
with IL-10 resulted in a 43% reduction in proliferation of clone
C97.1C8 compared with T cells stimulated with untreated MX
(experiment II). Furthermore, when IL-10 was continuously
present during the assay, proliferation of clone C97.1C8 cul-
tured with IL-10-pretreated Mq was further reduced (experi-
ment II). Similar results were achieved when 1-day M4 were
used to stimulate clone G1.3G10. In two experiments (III and
IV), the response of the T cells to F. hepatica antigen was
reduced by 37 and 67%, respectively, when IL-10-pretreated
M4) were used as AC, compared with untreated M+. The
inclusion of IL-10 in the assay with IL-10-pretreated M4 again
resulted in further inhibition of T-cell responses. Together,
these experiments show that under certain conditions, IL-10
can significantly inhibit antigen-dependent Th-cell prolifera-
tion by acting on the AC, which is presumably a M+. In the
case of clone G1.3G10, the inhibitory effect on the M4 was
only detected when the Mp were treated early after their
selection from PBMC by adherence, suggesting that by 6 days,
these cells can be refractory to the inhibitory action of IL-10.
The levels of expression of MHC class II on the surface of
either 1- or 6-day M( was not significantly reduced by treat-
ment with IL-10 (data not shown), indicating that an impair-
ment in MHC class II expression does not explain the reduced
T-cell proliferation in these studies.
DISCUSSION
IL-10 is a pluripotent immunoregulatory cytokine that has
not been previously characterized in T-cell clones of cattle.
Bovine IL-10 is not only genetically and biochemically more
similar to human than murine IL-10 (19); the results presented
here also demonstrate that bovine T cells behave more like
human T cells in their unrestricted IL-10 expression patterns
and regulation by this cytokine. The recent production of a
bovine IL-10 cDNA clone has enabled the characterization of
IL-10 gene transcription in different T-cell subsets. Analysis of
mRNA expression by several ThO, Thl, and Th2 clones specific
for parasite antigens provides the first evidence that IL-10 is
expressed by all three subsets of Th clones in cattle, indepen-
dent of antigenic specificity or expression of other cytokines.
Although we are unable to measure IL-10 protein expression
because of the lack of specific reagents, a comparison of IL-10
and actin signals on RNA blots exposed for the same time
TABLE 6. Inhibition of antigen-induced Th-cell proliferation by M, pretreated with IL-10
Radioactivity (mean cpm ± SD) incorporated
Expt no. T-cell clone MX by Th clones cultured withb: % InhibitionC
and M4 (Th phenotype) pretreatment' Antigen Antigen + IL-10
(% inhibition) (% inhibition)
I (7-day M+) C97.1C8 (Thl) Medium NDd ND
IL-10 2,800 ± 837 560 + 126 80
II (7-day M+) C97.1C8 (Thl) Medium 2,237 ± 27 1,773 ± 171 21
IL-10 1,281 ± 5 (43**) 676 + 161 (62*) 47*
III (1-day M+) G1.3G10 (Th2) Medium 1,963 ± 108 918 + 140 53*
IL-10 1,235 ± 11 (37**) 584 + 396 (33) 62
IV (1-day M+) G1.3G10 (Th2) Medium 3,136 ± 70 1,445 ± 464 54*
IL-10 1,038 ± 443 (67*) 232 + 40 (84) 78
a PBMC were allowed to adhere to plastic dishes for 1 to 2 h, and the adherent cells were cultured for an additional 20 h with either medium or IL-10 (20 ng/ml)
(1-day M+), or plastic-adherent PBMC were cultured for 6 days and then treated for an additional 20 h with medium or IL-10 (7-day M+).b Purified M4 (5 x 103) and Th cells (3 x 104) were cultured in the presence of specific antigen (5 p.g of Bb-1 per ml for experiment I and 25 ,ug of Bb-1 or 50 ,ug
of F. hepatica per ml for experiments II to IV) and in the absence or presence of IL-10 (80 ng/ml). [251I]deoxyuridine incorporation was determined as described in
Table 2, footnote a. Background proliferative responses of the clones cultured in the absence of antigen were c70 cpm for C97.1C8 and '105 cpm for G1.3G10. The
percent inhibition of the response of T cells and antigen cultured with IL-10-pretreated M4 compared with the response of T cells and antigen cultured with untreated
M4 is shown in parentheses. The level of significance, determined by the one-tailed Student t test, is indicated: *, P < 0.05; **, P < 0.01.
c Percent inhibition of the response of T cells cultured with M4< and antigen with IL-10 in the assay mix compared with the response of cells cultured without IL-10.
The level of significance, determined by the one-tailed Student t test, is indicated.
d ND, not determined.
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periods indicates that IL-10 mRNA expression by Thl clones is
equal to, if not stronger than, that by Th2 or ThO clones. These
results are comparable to those of Yssel and coworkers (35)
and Del Prete et al. (11), who similarly demonstrated IL-10
mRNA expression by both Thl- and Th2-like clones of human
T cells stimulated with antigen, ConA, or phorbol myristate
acetate plus anti-CD3 antibody, and at variance with the
results of Fiorentino et al. (17), who reported that IL-10 was
selectively expressed by Th2 cells in mice. IL-10 mRNA was
not detected in either of two bovine CD8+ clones, and
although the number of clones is small, this finding supports
the view that CD8+ T cells are poor producers of IL-10 (36).
Time course studies suggested that, following activation,
IL-10 is expressed earlier in bovine T cells than in human T
cells. We previously showed that IL-10 mRNA expression was
elevated by 8 h following activation of resting PBMC with
ConA (19), whereas IL-10 mRNA expression in mitogen-
activated human PBMC peaked after 24 h (35). Similarly, the
kinetics of expression of IL-10 in activated bovine T-cell clones
revealed higher levels of mRNA at 8 h than at later time
points, once again contrasting with the results of Yssel et al.,
who found that IL-10 expression in human T cell clones was
maximal at 24 h following stimulation (35). The reasons for
these differences are not clear, but one possibility is that the
mode of T-cell activation differed in the two studies. The
studies here used ConA to mimic antigen-induced T-cell
activation, whereas those reported by Yssel and coworkers
used a phorbol ester and anti-CD3 antibody. Other bovine
cytokine transcripts, including IL-4 (20) and IL-2 (34), were
maximally expressed from 2 to 4 h after stimulation, like the
human cytokines (35). Thus, the relatively later expression of
bovine IL-10 than of IL-2 and IL-4 is consistent with the
hypothesis that IL-10 serves to dampen an ongoing T-cell
proliferative response (11).
The ability of human IL-10 to inhibit proliferation of all
Th-cell subsets is also similar to results reported by others for
human Th clones (11, 12). In experiments performed with
bovine and human Th-cell clones, human IL-10 strongly sup-
pressed antigen-induced proliferation of both Thl and Th2
cells, and IL-2 reversed the suppressed proliferation. These
results indicate that for bovine as well as human T cells, the
immunoregulatory effects of IL-10 are not restricted to type 1
or delayed-type hypersensitivity responses.
The majority of studies with mouse and human T-cell clones
have indicated that IL-10 exerts its suppressive effects on Th
cells by indirectly affecting AC function (12, 14, 15, 17, 18).
Furthermore, the AC functions of M, and not B cells were
inhibited by IL-10 (12, 15, 18). Studies with murine T cells
showed that even though the inhibitory effects of IL-10-
pretreated M4) on T-cell function were variable, when IL-10
was added to cultures of T cells, antigen, and M+, T-cell
proliferation and cytokine production were inhibited (15, 18).
In the mouse studies, the mechanism ofM+ inhibition by IL-10
was not due to downregulation of MHC class II expression (14,
15, 18), but IL-10 was shown to prevent the induction on M4
membranes of another molecule, B7, the ligand for CD28
required for T-cell activation (14). The results of our experi-
ments with bovine T cells are also consistent with the view that
IL-10 suppresses Th-cell proliferation by indirectly affecting a
M+ costimulatory function(s), which is supported by the
following observations: (i) the source of AC used in the IL-10
inhibition studies was irradiated (3,000 rads) PBMC, and since
B cells are radiosensitive (1), the functional AC is likely to be
a monocyte or M+; (ii) only AC-dependent proliferative
responses of CD4+ T-cell clones against ConA were inhibited
by IL-10; ConA responses that were not augmented in the
presence of AC were not inhibited by IL-10; (iii) IL-2-induced
proliferation was inhibited only in the presence of AC; and (iv)
pretreatment of M4) with IL-10 partially inhibited antigen-
driven proliferation of both Thl and Th2 clones; however, as
reported for murine Thl cells (18), inhibition was further
augmented when IL-10 was continuously present during the
proliferation assay. M4 isolated by adherence to plastic were
less sensitive to the effects of IL-10 than freshly isolated
irradiated PBMC and could not be reproducibly suppressed.
One explanation for this is that activation of bovine M4) by
adherence to plastic could result in the expression of B7 or
other costimulatory molecules, rendering the cells resistant to
the effects of IL-10. In mice, B7 expression was induced on M4~
by overnight culture of the cells, and once upregulated, could
not be inhibited by IL-10 (14).
The effects of exogenous IL-10 on bovine T-cell clones were
variable, as seen by others with murine T cells (17, 22). In
contrast to the Th clones, one CD8+ clone was inhibited by
IL-10 independent of AC. In addition, B. bovis-specific Thl
clone G3.2F7 could not be inhibited by IL-10 in the absence or
presence of either irradiated PBMC or cultured M4, suggest-
ing that this T-cell clone has unique requirements for costimu-
lation. The inability of IL-10 to inhibit this clone cannot be due
to selective antigen presentation by B cells, since the clone
responded strongly to antigen presented by 7-day Mf (38,980
+ 3,426 cpm, compared with a background response of 672 ±
12 cpm). Previous studies with clone G3.2F7 demonstrated low
levels of IL-2 in the supernatant of activated cells (5), suggest-
ing that the lack of downregulation of proliferation by IL-10 is
not due to overriding effects of high levels of endogenous IL-2.
In contrast to the results obtained with the other Th clones,
IL-10 augmented antigen-induced proliferation of clone
G3.2F7. Furthermore, in the absence of AC, IL-10 also
enhanced proliferation of other ThO, Thl, and Th2 clones
stimulated by a low concentration of IL-2. MacNeil et al.
similarly reported that IL-10 acted as a costimulatory factor for
purified murine splenic CD4+ T cells in the presence of
saturating levels of IL-2 and IL-4 (23).
A comparison of the effects of IL-10 on bovine Th cells that
expressed IL-2 with the effects on clones that did not express
IL-2 revealed additional differences. IL-2 more effectively
restored the antigen-specific proliferative responses of clones
that expressed IL-2 mRNA than those ThO and Th2 clones that
did not. In addition, T-cell clones that did not express IL-2
were dependent on AC for a proliferative response to ConA,
and only these IL-2-negative clones were suppressed by IL-10
when stimulated with the mitogen and AC. Together, our
results with bovine Th clones support the hypothesis that the
suppressive or costimulatory effects of IL-10 are not predicated
by the subset of responder T cell per se, but by the nature of
the cytokines expressed by and the costimulatory requirements
of these T cells (14, 15). Studies are in progress to determine
whether expression of a B7 homolog on bovine MX is similarly
regulated by IL-10 and if the differential effects of IL-10 on the
T-cell clones are related to differential requirements for B7 as
a costimulatory ligand. Studies examining the ability of B cells
to serve as antigen-presenting cells for selected Th clones are
also planned.
In addition to inhibiting potential costimulatory molecules
on AC, IL-10 may suppress T-cell proliferation through re-
duced transcription of autocrine growth factor genes. Al-
though the effects of IL-10 on IL-2 expression have not been
demonstrated, IL-4 mRNA expression was inhibited in two
IL-10-treated ThO clones. IL-10 also downregulated expression
of IFN--y in the two ThO clones at both the protein and mRNA
levels, as shown for murine and human Thl clones (11, 17).
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Additional experiments are needed to more clearly define the
relationships between the inhibitory or costimulatory effects of
IL-10 on Th-cell proliferation and regulation of cytokine gene
and protein expression. Studies are in progress to compare the
effects of exogenous IL-10 on IL-2, IL-4, IFN--y, and IL-10
mRNA expression by bovine ThO, Thl, and Th2 clones that we
have characterized as having differential responses to IL-10.
In summary, this study shows that in cattle, as in humans,
IL-10 does not discriminate between Thl and Th2 cells, but
downregulates AC-dependent proliferation by different sub-
types of T cells, independent of other cytokines expressed.
Thus, the cytokine network that regulates Thl and Th2 cells
that has been defined for inbred strains of mice may not be
generally applicable to all mammals (11). Our studies further
show that the bovine host provides an additional system with
which to study T-cell responses against selected pathogens in
outbred species.
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